New Bedside Genetic Testing Could Boost Stroke Survival

Description

A revolutionary point-of-care testing device that could help to prevent recurrent strokes could soon be rolled out across the NHS, according to researchers at the University of Manchester. The shoebox-sized device enables bedside testing using a cheek swab to detect genetic changes that reduce the effectiveness of clopidogrel, the current first line preventive treatment, so that alternative antiplatelet therapy can be prescribed.